Effects of perceptive rehabilitation and mobilization methods on symptoms and disability in patients with fibromyalgia: A preliminary randomized control trial.

Fibromyalgia has no cure, so treatment research usually focuses on easing symptoms and disability. This preliminary randomized controlled trial compared perceptive rehabilitation and soft tissue and joint mobilization against a control group in 55 patients with fibromyalgia, measuring impact on daily life (using the Revised Fibromyalgia Impact Questionnaire), pain, fatigue, depression, and sleep quality at baseline, after 8 weeks of treatment, and again at 3 months. Both treatment groups showed statistically significant improvements over the control group at 8 weeks for most measures, though the mobilization group did not differ significantly from control on the overall impact score, and sleep quality showed no group differences at any point. By 3 months, nearly all these advantages had faded, with only depression remaining different between groups.

The authors describe the study as preliminary, and the disappearance of benefits over time is the key limitation to keep in mind.

If you have fibromyalgia, you know that treatments tend to aim at reducing symptoms rather than curing the condition. This small study looked at whether two hands-on approaches, called perceptive rehabilitation and mobilization (a form of soft tissue and joint therapy), could help more than no treatment at all.

It included 55 people with fibromyalgia, split into three groups: one received perceptive rehabilitation, one received mobilization, and one served as a control group with no active treatment. After 8 weeks, people in both treatment groups reported feeling better than those in the control group on measures of pain, fatigue, depression, and overall fibromyalgia impact, though sleep quality did not differ between groups at any point, and the mobilization group did not stand out from control on the overall impact score specifically. The disappointing part is that by 3 months, most of these improvements had faded, with only depression scores still showing a difference.

Because this was a small, preliminary trial, these findings can't tell us whether the benefits would last with continued treatment or a different approach.

This is a summary of research, not medical advice. Talk to your own healthcare provider about anything affecting your care.

This preliminary RCT randomized 55 fibromyalgia patients to perceptive rehabilitation, soft tissue and joint mobilization, or a control condition, assessing the FIQR as the primary outcome alongside pain, fatigue, depression, and sleep quality at baseline, end of 8-week treatment, and 3-month follow-up. Both intervention groups showed statistically significant between-group differences versus control at the end of treatment across most measures, with the exception that mobilization did not differ significantly from control on the FIQR overall impact score, and sleep quality showed no significant between-group differences at any time point. By the 3-month follow-up, nearly all treatment effects had regressed toward the control group, with depression being the sole outcome retaining a statistically significant between-group difference.

The trial does not report which specific components of either intervention drove the short-term gains, and the modest sample size across three arms limits precision and generalizability. The abstract does not describe adverse events, so no safety conclusions can be drawn.

The authors themselves frame this as preliminary work and call for further research into maintaining improvements, which should temper any clinical interpretation of durability or superiority between the two active approaches.